✦ LIBER ✦

Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: Analysis of SEAS and JUPITER trials

✍ Scribed by A. Poli; A. Corsini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

254: Evaluation of cardiovascular risk a

✍ Ferrières, Jean; Dallongeville, Jean; Kownator, Serge; Guillaume, Xavier; Thomas 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 61 KB

PMD4 Cardiovascular Risk Prevalence in H

✍ S. Kownator; J. Ferrieres; E. Bruckert; G. Bonnélye; F. Thomas-delecourt; P.H. D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Lipid and cardiovascular effects of stat

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

LB-OR-2 HIGH HDL-C AND CHD RISK IN STATI

✍ Holme, I.; Kastelein, J.J.P.; Faergeman, O.; Larsen, M.L.; Lindahl, C.; Olsson, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Plasma Triglycerides and Cardiovascular

✍ Ole Faergeman; Ingar Holme; Rana Fayyad; Sonal Bhatia; Scott M. Grundy; John J.P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Increased risk for cardiovascular outcom

✍ Toshitsugu Ishikawa; Hideki Ito; Yasuyoshi Ouchi; Yasuo Ohashi; Yasushi Saito; H 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 982 KB